Boston Scientific Expands Neuromodulation And Obesity Trials As Valuation Stays Rich [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Boston Scientific (NYSE:BSX) is expanding its neuromodulation presence through the acquisitions of Nalu Medical and Valencia Technologies. The company recently shared new clinical data on spinal cord stimulation therapies for pain management. Boston Scientific also launched a clinical study in Asia to evaluate the OverStitch NXT device for obesity treatment. Boston Scientific, trading at $92.33, is moving further beyond its traditional cardiology roots into neurology and obesity treatment. The stock shows mixed recent performance, with a 1.1% gain over the past week and a 3.8% decline over the past month, while longer horizons such as 3 years and 5 years show cumulative returns of 92.1% and 138.2% respectively. For investors, these moves highlight a company that is actively broadening its product mix and clinical footprint. The combination of pain management technologies and obesity focused trials in Asia could influence how Boston Scientific's revenue base and competitive po
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific Stock: Analyst Estimates & Ratings [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Corporation (BSX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Is Boston Scientific (BSX) Pricing In Too Much Optimism After Mixed Share Performance? [Yahoo! Finance]Yahoo! Finance
- Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific's (BSX) Mew Market Dominance [Yahoo! Finance]Yahoo! Finance
- Prospect Medical bankruptcy dispute puts CT hospitals at risk of supply disruptions, attorney says [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 1/21/26 - Form 425
- 1/15/26 - Form 8-K
- 1/15/26 - Form 8-K
- BSX's page on the SEC website